User profiles for Magdalene Joseph

Magdalene Joseph

Verified email at nhs.net
Cited by 2001

[HTML][HTML] A dynamic COVID-19 immune signature includes associations with poor prognosis

…, I Francos-Quijorna, S Kamdar, M Joseph… - Nature medicine, 2020 - nature.com
Improved understanding and management of COVID-19, a potentially life-threatening disease,
could greatly reduce the threat posed by its etiologic agent, SARS-CoV-2. Toward this end…

[HTML][HTML] Safety and immunogenicity of one versus two doses of the COVID-19 vaccine BNT162b2 for patients with cancer: interim analysis of a prospective …

…, PL Lee, J Eum, MC Poole, M Joseph… - The Lancet …, 2021 - thelancet.com
Background The efficacy and safety profiles of vaccines against SARS-CoV-2 in patients with
cancer is unknown. We aimed to assess the safety and immunogenicity of the BNT162b2 (…

[HTML][HTML] Immune responses in bladder cancer-role of immune cell populations, prognostic factors and therapeutic implications

M Joseph, D Enting - Frontiers in oncology, 2019 - frontiersin.org
Immunosurveillance, which describes the immunologically mediated elimination of transformed
cells, has been widely accepted in the context of bladder cancer for many decades with …

[HTML][HTML] A local human Vδ1 T cell population is associated with survival in nonsmall-cell lung cancer

…, S Veeriah, J Czyzewska-Khan, C Morton, M Joseph… - Nature cancer, 2022 - nature.com
Murine tissues harbor signature γδ T cell compartments with profound yet differential impacts
on carcinogenesis. Conversely, human tissue-resident γδ cells are less well defined. In the …

Global patterns of antigen receptor repertoire disruption across adaptive immune compartments in COVID-19

M Joseph, Y Wu, R Dannebaum… - Proceedings of the …, 2022 - National Acad Sciences
Whereas pathogen-specific T and B cells are a primary focus of interest during infectious
disease, we have used COVID-19 to ask whether their emergence comes at a cost of broader B …

[PDF][PDF] Neutralization potency of monoclonal antibodies recognizing dominant and subdominant epitopes on SARS-CoV-2 Spike is impacted by the B. 1.1. 7 variant

…, JM Jimenez-Guardeño, AG Laing, Y Wu, M Joseph… - Immunity, 2021 - cell.com
Interaction of the SARS-CoV-2 Spike receptor binding domain (RBD) with the receptor
ACE2 on host cells is essential for viral entry. RBD is the dominant target for neutralizing …

Interim results of the safety and immune-efficacy of 1 versus 2 doses of COVID-19 vaccine BNT162b2 for cancer patients in the context of the UK vaccine priority …

…, IF Quijorna, P Lee, J Eum, MC Poole, M Joseph… - MedRxiv, 2021 - medrxiv.org
Background The efficacy and safety profile of vaccines against severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) have not been definitively established in …

A consensus Covid-19 immune signature combines immuno-protection with discrete sepsis-like traits associated with poor prognosis

…, TS Hayday, I Francos-Quijorna, S Kamdar, M Joseph… - MedRxiv, 2020 - medrxiv.org
Person-to-person transmission of SARS-CoV-2 virus has triggered a global emergency
because of its potential to cause life-threatening Covid-19 disease. By comparison to …

Author Correction: A dynamic COVID-19 immune signature includes associations with poor prognosis

…, I Francos-Quijorna, S Kamdar, M Joseph… - Nature medicine, 2020 - nature.com
In the version of this article initially published online, a statement of support was missing from
the Acknowledgements section. The correct ending of the fourth sentence of that section is …

[HTML][HTML] Impact of the B. 1.1. 7 variant on neutralizing monoclonal antibodies recognizing diverse epitopes on SARS-CoV-2 Spike

…, JM Jimenez-Guardeno, AG Laing, Y Wu, M Joseph… - bioRxiv, 2021 - ncbi.nlm.nih.gov
The interaction of the SARS-CoV-2 Spike receptor binding domain (RBD) with the ACE2
receptor on host cells is essential for viral entry. RBD is the dominant target for neutralizing …